Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
gene editing
6
×
life sciences
national blog main
6
×
biotech
boston blog main
boston top stories
san francisco blog main
boston
crispr
national top stories
san francisco top stories
deals
editas medicine
allergan
clinical trials
cynthia collins
enzyme
feng zhang
sangamo therapeutics
vc
abbvie
administration
agios therapeutics
alzheimer's
alzheimer's disease
amgen
base editing
bellicum pharmaceuticals
biogen
biomarin pharmaceutical
biontech
boulder/denver blog main
boulder/denver top stories
branden moriarty
breakpoint therapeutics
broad institute
cancer
car-t
cas13
celgene
What
gene
6
×
editing
crispr
editas
medicine
bio
experimental
humans
medicines
therapeutics
therapy
trial
abbvie
allergan
alliance
beam
becker
benefit
billions
biotech
blessing
bosley
cas
ceo
check
clinical
create
cusp
depart
diagnostic
diseases
dollars
eaton
editor
exits
fix
founders
genetic
going
gotten
Language
unset
Current search:
" national blog main "
×
gene
×
" gene editing "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M